View This Report »
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects Summary Type 2 diabetes ...
The global insulin market is expected to reach USD 42 billion by 2020, growing at a CAGR of XX%. Insulin is a peptide hormone secreted by the beta cells in the pancreas. Insulin maintains the metabolism ...
Changing lifestyles, rapid urbanization and cheap calories in the form of processed foods are putting more and more people at risk of developing Type-2 diabetes in Asia. Despite having a lower body weight, ...